Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

Recruiting now · Not applicable

Conditions studied: Colorectal Carcinoma

In brief

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Key facts

Study ID

NCT05447923

Run by

Mayo Clinic

People needed

450

Starts

2022-05-22

Expected to finish

2030-06-01

Last updated by the study team

2026-04-02

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 45 years of age or older
• No prior history of colorectal cancer or colon polyps
• No first-degree family history of colorectal cancer who were diagnosed under age 60
• No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
• Have not undergone a colonoscopy in the last 5 years
• Have not had a fecal immunochemical test (FIT) test within the last year
• Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area

Where it is running

• Mayo Clinic in Arizona — Scottsdale, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.